Pfizer (PFE) Tops Q1 EPS by 10c; Bumps EPS Outlook

Pfizer (NYSE: PFE) reported Q1 EPS of $0.85, $0.10 better than the analyst estimate of $0.75. Revenue for the quarter came in at $13.1 billion versus the consensus estimate of $12.99 billion.

GUIDANCE:

Pfizer raises midpoint of FY2019 EPS by 1 cent to $2.83-$2.93, versus the consensus of $2.89. Reaffirmed 2019 Financial Guidance for Revenues

For earnings history and earnings-related data on Pfizer (PFE) click here.

You May Also Be Interested In

• BJ's Wholesale Club (BJ) Tops Q2 EPS by 19c, Beats on Revenue; Offers FY27 EPS Guidance
• TJX Cos. (TJX) Tops Q2 EPS by 3c, Beats on Revenue; Offers FY27 EPS Guidance
• Analog Devices (ADI) Tops Q3 EPS by 11c, Beats on Revenue; Offers Q4 Guidance